Cardiovascular Effects of GLP-1 Receptor Activation

NCT03101930 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

329

Enrollment

OTHER

Sponsor class

Conditions

Obesity
PreDiabetes

Interventions

DRUG: Liraglutide
DRUG: Sitagliptin
OTHER: hypocaloric diet
DRUG: Placebos
DRUG: Exendin (9-39)

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]